This is keeping with the lack, until recently, of any randomized trial focusing on this issue. Some more robust evidence on DAPT has been published recently (5), and further insights will be provided by their synthesis with pairwise and network meta-analyses (6,7). On one hand, the 12-month dogma has been challenged and shorter-term regimens envisioned. Yet, the DAPT (Dual Antiplatelet Therapy) study has highlighted that a 30-month regimen may reduce thrombotic events, albeit at the possible expense of an increase in apparently noncardiovascular death (5). The scenario on the most appropriate antithrombotic management after coronary stenting is also compounded by the large evidence base suggesting that premature cessation of DAPT is prognostically unfavorable (8,9). There is, however, a problem with terminology because different types of cessation can occur ( Table 1) .
This issue of JACC: Cardiovascular Interventions
provides incremental data with the EDUCATE registry (10) . This 2,265-patient prospective observational study focused on nonadherence to DAPT after PCI (originally prescribed for 12 months). Nonadherence was defined as missing $1 day of DAPT, whereas severe nonadherence was defined as missing $2 weeks.
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